Skip to content
Brand AI

Arcus Biosciences

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    Gilead and Arcus sign oncology collaboration deal

    Gilead Sciences signed a 10-year collaboration deal with Arcus Biosciences to co-develop and co-commercialise current and future cancer therapeutic candidates in Arcus's pipeline. The deal is valued at up to $1.97 billion.

    Source